Research Tracker›Biomarker Atlas›Multiple Sclerosis›CSF Oligoclonal Bands

CSF Oligoclonal Bands in Multiple Sclerosis

In Multiple Sclerosis, published studies report higher levels of CSF Oligoclonal Bands than in the reference group of the cited comparison (MS vs healthy (diagnostic marker)). The source does not tie this marker to a specific symptom cluster, so it is best read as a biological signal rather than a symptom predictor. The evidence summarised here comes from Mukherjee et al. 2025 and reflects averages across cohorts rather than any single patient's result.

↑ ElevatedNeurological

Summary

Direction in Multiple Sclerosis↑ Elevated — higher than in the comparison group
CategoryNeurological
Compared againstMS vs healthy (diagnostic marker)
SourceMukherjee et al. 2025 — doi:10.1007/s11910-025-01432-8
Condition atlasMultiple Sclerosis Biomarker Atlas

Other conditions where CSF Oligoclonal Bands is reported

See the cross-condition hub: CSF Oligoclonal Bands across conditions.

Related Neurological markers in Multiple Sclerosis

Full list: Multiple Sclerosis Biomarker Atlas.

Frequently asked questions

Is CSF Oligoclonal Bands high or low in Multiple Sclerosis?

Elevated. Studies summarised in the OSMF atlas report higher CSF Oligoclonal Bands in Multiple Sclerosis than in the reference group of the cited comparison (MS vs healthy (diagnostic marker)). Source: Mukherjee et al. 2025.

Which test measures CSF Oligoclonal Bands?

The atlas record does not list a standardised clinical test code (LOINC) for CSF Oligoclonal Bands, which usually means it was measured with research assays or study-specific protocols rather than a routine clinical panel. Check the cited source for the exact method.

Is one abnormal CSF Oligoclonal Bands result diagnostic of Multiple Sclerosis?

No. No single biomarker is diagnostic of Multiple Sclerosis. CSF Oligoclonal Bands findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Is CSF Oligoclonal Bands specific to Multiple Sclerosis?

No. The same marker is also reported in Lyme Disease in this atlas, so it reflects shared biology (for example inflammation or vascular stress) rather than a condition-specific signature.

Cite this page

Open Source Medicine Foundation. (2026). CSF Oligoclonal Bands in Multiple Sclerosis: direction, evidence and what it means. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/multiple-sclerosis/csf-oligoclonal-bands.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-07-03 · Page generated from multiple-sclerosis.json · Browse: Multiple Sclerosis atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.